Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Risk Factors Associated With the Onset of Oral Mucositis/Stomatitis and Ocular Surface Events (OSE) in Patients With Non-small Cell Lung Cancer (NSCLC) and HER2-negative Breast Cancer (BC)

NCT06686602 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT06686602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06686602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Risk Factors Associated With the Onset of Oral Mucositis/Stomatitis and Ocular Surface Events (OSE) in Patients With Non-small Cell Lung Cancer (NSCLC) and HER2-negative Breast Cancer (BC)
Lead sponsor
Daiichi Sankyo
Phase
Observational
Overall status
Completed
Start date
July 9, 2024
Completion date
March 18, 2025
Enrollment
13,759 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced/metastatic her2-negative breast cancer, advanced/metastatic nsclc